[
  {
    "ts": "2025-09-26T15:43:00+00:00",
    "headline": "AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices",
    "summary": "AstraZeneca said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for pharmaceutical companies to cut drug prices.",
    "url": "https://www.wsj.com/health/pharma/astrazeneca-to-offer-discounted-drugs-as-trump-pressures-pharma-industry-to-cut-prices-66f0a8dc?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "a180de9a-9401-39a7-bf76-7aac31cdc1e3",
      "content": {
        "id": "a180de9a-9401-39a7-bf76-7aac31cdc1e3",
        "contentType": "STORY",
        "title": "AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices",
        "description": "",
        "summary": "AstraZeneca said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for pharmaceutical companies to cut drug prices.",
        "pubDate": "2025-09-26T15:43:00Z",
        "displayTime": "2025-09-26T15:43:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a180de9a-9401-39a7-bf76-7aac31cdc1e3/astrazeneca-to-offer.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/ecf44880aa94cd2a05414a3d0ba54e4a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TuYWgr6AYLgo1I_B6JttNg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/ecf44880aa94cd2a05414a3d0ba54e4a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eU_o0KahJ1HbPaK7.FHkkw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/ecf44880aa94cd2a05414a3d0ba54e4a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/astrazeneca-to-offer-discounted-drugs-as-trump-pressures-pharma-industry-to-cut-prices-66f0a8dc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-26T14:46:04+00:00",
    "headline": "US, European pharma stocks steady after Trump's tariff move, Asia slips",
    "summary": "By Gregor Stuart Hunter and Andrew Silver SINGAPORE/SHANGHAI (Reuters) -Shares of U.S. and European pharmaceutical firms were little changed on Friday, while Asian drugmakers declined, after President",
    "url": "https://ca.finance.yahoo.com/news/us-european-pharma-stocks-steady-144604034.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "f13496e0-3091-3dc5-86a0-881e7bdf1ce7",
      "content": {
        "id": "f13496e0-3091-3dc5-86a0-881e7bdf1ce7",
        "contentType": "STORY",
        "title": "US, European pharma stocks steady after Trump's tariff move, Asia slips",
        "description": "",
        "summary": "By Gregor Stuart Hunter and Andrew Silver SINGAPORE/SHANGHAI (Reuters) -Shares of U.S. and European pharmaceutical firms were little changed on Friday, while Asian drugmakers declined, after President",
        "pubDate": "2025-09-26T14:46:04Z",
        "displayTime": "2025-09-26T14:46:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/cd37161c9c7167426d5422917aeb82cd",
          "originalWidth": 800,
          "originalHeight": 559,
          "caption": "FILE PHOTO: Daiichi Sankyo's company logo is pictured at its headquarters in Tokyo, Japan, October 20, 2023. REUTERS/Kim Kyung-Hoon/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3j6vQJHyN3KImouGk3F8kw--~B/aD01NTk7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/cd37161c9c7167426d5422917aeb82cd.cf.webp",
              "width": 800,
              "height": 559,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tcvEFco1f57BeF8Sl9AOlg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/cd37161c9c7167426d5422917aeb82cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/us-european-pharma-stocks-steady-144604034.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-european-pharma-stocks-steady-144604034.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-26T13:40:00+00:00",
    "headline": "MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?",
    "summary": "Merck and Bristol Myers face diverging growth paths, with Keytruda driving MRK's momentum and BMY navigating generic headwinds.",
    "url": "https://finance.yahoo.com/news/mrk-vs-bmy-pharma-stock-134000647.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1e92af2a-9957-350c-ac88-07fc90badd34",
      "content": {
        "id": "1e92af2a-9957-350c-ac88-07fc90badd34",
        "contentType": "STORY",
        "title": "MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?",
        "description": "",
        "summary": "Merck and Bristol Myers face diverging growth paths, with Keytruda driving MRK's momentum and BMY navigating generic headwinds.",
        "pubDate": "2025-09-26T13:40:00Z",
        "displayTime": "2025-09-26T13:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NuaC8R_wAbhCY5KPvmp9LA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cLIW4zpH3bXqWfT.Oe9Uew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mrk-vs-bmy-pharma-stock-134000647.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mrk-vs-bmy-pharma-stock-134000647.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-26T11:24:59+00:00",
    "headline": "Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says",
    "summary": "The good news: There are several loopholes in Trump’s proposal that mean the impact of the new taxes may be limited.",
    "url": "https://finance.yahoo.com/news/trump-overnight-demand-100-tariffs-112459533.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "720c84e3-86fe-3627-8740-d74a57d01f80",
      "content": {
        "id": "720c84e3-86fe-3627-8740-d74a57d01f80",
        "contentType": "STORY",
        "title": "Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says",
        "description": "",
        "summary": "The good news: There are several loopholes in Trump’s proposal that mean the impact of the new taxes may be limited.",
        "pubDate": "2025-09-26T11:24:59Z",
        "displayTime": "2025-09-26T11:24:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/51e1ffd9d1cc11dc4a8b49c7edfb24e2",
          "originalWidth": 2048,
          "originalHeight": 1365,
          "caption": "President Donald Trump in the Oval Office of the White House on Sept. 25, 2025.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kLHH2kp2WozZ0f0gPXdYXQ--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/51e1ffd9d1cc11dc4a8b49c7edfb24e2.cf.webp",
              "width": 2048,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wlo_V_nAVphjaqOCynj45w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/51e1ffd9d1cc11dc4a8b49c7edfb24e2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trump-overnight-demand-100-tariffs-112459533.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trump-overnight-demand-100-tariffs-112459533.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "4519.T"
            },
            {
              "symbol": "4506.T"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-26T08:41:42+00:00",
    "headline": "Is pharma’s IRA pricing battle running out of steam?",
    "summary": "Despite recent court losses, the legal tides could still turn in the industry’s favor.",
    "url": "https://www.pharmavoice.com/news/pharma-drug-ira-scotus-supreme-court-pricing-lawsuit/761133/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "6078ea05-af5a-33d7-914e-d21513e51871",
      "content": {
        "id": "6078ea05-af5a-33d7-914e-d21513e51871",
        "contentType": "STORY",
        "title": "Is pharma’s IRA pricing battle running out of steam?",
        "description": "",
        "summary": "Despite recent court losses, the legal tides could still turn in the industry’s favor.",
        "pubDate": "2025-09-26T08:41:42Z",
        "displayTime": "2025-09-26T08:41:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/84b1630b0d1faf45b0c351087cc8b65f",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5M0BER0jA2LS173pzUTpsw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/84b1630b0d1faf45b0c351087cc8b65f.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bzj3Ef5jnYAwDTSueF2g_g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/84b1630b0d1faf45b0c351087cc8b65f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/pharma-drug-ira-scotus-supreme-court-pricing-lawsuit/761133/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-ira-pricing-battle-running-084142366.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "NOVN.SW"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]